Has Stacey Eason received payments from drug or device companies?

Yes. Drug and device makers reported $3,187 in general payments to Stacey Eason across 154 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stacey Eason did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stacey Eason come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stacey Eason

Psychiatric/Mental Health · Wichita, KSNPI 1306481189

Payments from drug & device makers

$3,187in general payments, 2019–2025

Across 154 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$868
Johnson & Johnson$272
Axsome Therapeutics, Inc.$261
Corium, LLC$221
Otsuka America Pharmaceutical, Inc.$204
Supernus Pharmaceuticals, Inc.$163
plus $1K from 25 others

What the payments were for

Food & beverage$3,187100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	47	$868
Johnson & Johnson	4	$272
Axsome Therapeutics, Inc.	9	$261
Corium, LLC	12	$221
Otsuka America Pharmaceutical, Inc.	11	$204
Supernus Pharmaceuticals, Inc.	3	$163
Vanda Pharmaceuticals Inc.	6	$149
Lundbeck LLC	7	$126
E.r. Squibb & Sons, L.L.C.	4	$99
Merck	6	$93
Neos Therapeutics, LP	4	$91
Novo Nordisk	5	$76
Lilly USA, LLC	5	$69
Idorsia Pharmaceuticals US Inc	4	$63
Amgen	4	$53
Biogen	2	$40
Teva Pharmaceuticals USA, Inc.	2	$38
Daiichi Sankyo Inc.	2	$36
Myovant Sciences Inc.	2	$33
Ironshore Pharmaceuticals Inc.	2	$32
Therapeuticsmd, Inc.	2	$29
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$28
Collegium Pharmaceutical, Inc.	1	$21
Alkermes, Inc.	1	$19
Mylan Pharmaceuticals Inc.	1	$16
Exeltis, USA Inc.	1	$15
Kowa Pharmaceuticals America, Inc.	1	$15
Bayer	1	$15
Sage Therapeutics, LLC	1	$15
Neurocrine Biosciences, Inc.	1	$14
Pfizer	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,187 in reported general payments places this provider in the 80th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
DayvigoLemborexant	11	$3,720
Ziprasidone Hcl	11	$1,184
Buspirone Hcl	33	$458
Prazosin Hcl	12	$406
Quetiapine Fumarate	16	$325
Clonazepam	16	$216
Fluoxetine Hcl	23	$146
Lorazepam	15	$107
Trazodone Hcl	13	$84
Levothyroxine Sodium	12	$75

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Wichita

Hayley KnappWichita$31K
Deborah MurphyWichita$13K
Julius QuinnWichita$10K
Ashley MeluginWichita$9K
Jacy BarkerWichita$9K
Susan MilehamWichita$8K
Angela TheobaldWichita$6K
Alyson Taylor-SmithWichita$5K
Ruth HartWichita$5K
Julia McVayWichita$5K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →